AI/ML Innovations Inc. Welcomes Industry Veterans to Board of Directors
Rhea-AI Summary
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF) has announced significant changes to its Board of Directors. Mark Orsmond, a veteran healthcare executive with over 30 years of experience, has been appointed as Executive Chair. Orsmond's track record includes successfully developing and selling three healthcare businesses to Well Health Technologies Corp., and serving as CFO and Executive VP at Corix Group and ALL-SEA Group.
Michael Nemirow joins as Director, bringing extensive entrepreneurial experience, notably as CEO of Greenstar Plant Products, which he led to global expansion before its acquisition by a U.S. public company in 2021. The company has also granted stock options to a director for 250,000 shares at $0.17 per share, vesting quarterly over one year.
Tim Daniels will step down as Executive Chairman but remain on the Board. These appointments align with AIML's focus on AI and machine learning in digital health and wellbeing solutions.
Positive
- Appointment of experienced healthcare executive Mark Orsmond as Executive Chair, bringing expertise in successful business exits
- Addition of Michael Nemirow as Director with proven track record in global business expansion and successful exit
Negative
- None.
Mark Orsmond, a highly respected business professional in Canadian Healthcare, Appointed Executive Chair
Michael Nemirow Joins as Director, Bringing Decades of Entrepreneurial Expertise
VANCOUVER, BC / ACCESSWIRE / January 9, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a leading company committed to acquiring and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce the appointment of two distinguished leaders to its Board of Directors. Mark Orsmond, a highly respected pioneer among healthcare executives in Canada, joins as Executive Chair, while seasoned business entrepreneur Michael Nemirow steps into the role of Director.
Mark Orsmond has earned a reputation as a transformative leader in Canada, with a career spanning over 30 years. Mark has successfully developed and scaled multiple ventures, including three healthcare businesses that were sold to Well Health Technologies Corp. (TSX: WELL). His extensive experience includes serving as CFO and Executive Vice President at the Corix Group of Companies and the ALL-SEA Group of Companies. A holder of a B.Compt degree from the University of South Africa and a CPA designation, Mr. Orsmond's leadership has consistently driven organizational success and premier exits.
Michael Nemirow brings an entrepreneurial acumen honed over decades of scaling and transforming businesses across diverse industries. As CEO of Greenstar Plant Products, Inc., Mr. Nemirow led a strategic overhaul, streamlining operations, acquiring a complementary organic brand, and driving the company's global presence in markets such as North America, South America, Europe, and Australia. Under his leadership, Greenstar grew into a globally recognized manufacturer and was acquired by a public U.S. company in 2021.
"We are privileged to welcome two exceptional leaders to our Board," said Paul Duffy, CEO of AIML. "Mark Orsmond's unparalleled influence in Canadian healthcare and Michael Nemirow's entrepreneurial expertise will be invaluable as AIML accelerates its global expansion and innovation in health technology. Their strategic guidance will be a cornerstone of our future success."
The Company also extends its gratitude to Tim Daniels for his leadership as Executive Chairman. Mr. Daniels will remain a valued member of the Board.
Stock Options Grant
The Company further announces the grant of stock options to a director to purchase up to 250,000 common shares of the Company ("Shares") at an exercise price of
For more information about AIML:
For detailed information please see AIML's website or the Company's filed documents at www.sedarplus.ca.
For further information, contact: Blake Fallis at (778) 405-0882 or info@aiml-innovations.com.
About AI/ML Innovations Inc. https://aiml-innovations.com/
AIML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence: (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through its acquisition of Quantum Sciences Ltd. (
On behalf of the Board of Directors
Tim Daniels, Director
The Canadian Securities Exchange has in no way passed upon the merits of the Company and has neither approved nor disapproved the contents of this press release. Neither the Canadian Securities Exchange nor the Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: AI/ML Innovations, Inc.
View the original press release on accesswire.com
FAQ
What changes were made to AIMLF's Board of Directors in January 2024?
What stock options did AIMLF grant in January 2024?
What is Mark Orsmond's background before joining AIMLF?
What is Michael Nemirow's business experience prior to AIMLF?
